Goldman Sachs Group Inc

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
Manager Name
Goldman Sachs Group Inc
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions
Manager:
Search and click to pin securities to the top
Page 234 of 253
TMC the metals Co Inc.
Shares:
122684
Value:
$211.0M
DLH Holdings Corp.
Shares:
51502(-11.6%)
Value:
$208.6M(-55.4%)
Orchestra BioMed Holdings, Inc.
Shares:
48729(-21.6%)
Value:
$208.6M(-16.1%)
Sky Harbour Group Corp
Shares:
16028(-61.5%)
Value:
$208.5M(-58.0%)
025072307
Shares:
2225(-83.3%)
Value:
$208.4M(-84.3%)
86280R886
Shares:
6840(+0.0%)
Value:
$208.3M(-3.7%)
Cartesian Therapeutics, Inc.
Shares:
15775(-42.7%)
Value:
$207.9M(-57.8%)
TAT TECHNOLOGIES LTD
Shares:
7537
Value:
$207.1M
74255Y201
Shares:
3124(+0.0%)
Value:
$206.2M(-7.8%)
Foghorn Therapeutics Inc.
Shares:
56332(-24.5%)
Value:
$205.6M(-41.6%)
Strawberry Fields REIT, Inc.
Shares:
17182(+13.9%)
Value:
$204.6M(+28.8%)
DESTINATION XL GROUP, INC.
Shares:
139799(-16.4%)
Value:
$204.1M(-54.6%)
17878Y207
Shares:
8858
Value:
$203.7M
Sanara MedTech Inc.
Shares:
6581(-46.6%)
Value:
$203.2M(-50.4%)
BlackRock Science & Technology Trust
Shares:
6147(+10.8%)
Value:
$202.8M(+0.0%)
25434V724
Shares:
4901
Value:
$202.0M
Mersana Therapeutics, Inc.
Shares:
586658(-26.9%)
Value:
$201.9M(-82.4%)
Upstream Bio, Inc.
Shares:
32955(-25.9%)
Value:
$201.7M(-72.4%)
Kyverna Therapeutics, Inc.
Shares:
104460(-7.9%)
Value:
$201.6M(-52.5%)
CHAMPIONS ONCOLOGY, INC.
Shares:
23129
Value:
$200.8M